Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
17.87
-0.44 (-2.40%)
Mar 3, 2025, 4:00 PM EST - Market closed
Pulse Biosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
56
Market Cap
1.10B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
PLSE News
- 11 days ago - Pulse Biosciences To Present at the TD Cowen 45th Annual Health Care Conference - Business Wire
- 27 days ago - Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer - Business Wire
- 4 weeks ago - Pulse Biosciences' Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting - Business Wire
- 5 weeks ago - Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium - Business Wire
- 7 weeks ago - Pulse Biosciences' Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium - Business Wire
- 7 weeks ago - Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer - Business Wire
- 2 months ago - Pulse Biosciences To Present at the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 2 months ago - Pulse Biosciences, Inc. Announces Planned Redemption of Warrants - Business Wire